What’s an ‘opt-out’ like you doing in a patent like this?
(NEW ARTICLE) Rarely has a choice between two options given rise to so much controversy as whether or not to…
Read more Back to Home 
G2/21 or rather when the abstract forest prevents you from seeing the trees
(NEW ARTICLE) For weeks now, patent practitioners have been discussing the content of the G2/21 decision, which should have shed…
Read moreSix paralegals in ZBM qualified with the EPAC certification!
We’re excited to announce that our colleagues from the formalities department Marga Ibáñez, Laura Santiago, …
Read moreIAM Global Leaders 2023
ZBM are pleased to announce that our distinguished experts Anna Barlocci, Carles Comes and …
Read moreZBM recognised by ‘Best Lawyers’ in 15th edition (2023)
We are delighted to announce that ZBM have yet again been recognised by the prestigious publication Best Lawyers in their…
Read moreCall for ICEX grants 2021 for the internationalisation of Spanish SMEs
The Spanish Official State Gazette (BOE) of 20 September 2021 published the regulatory bases and a …
Read moreZBM Patents and Trademarks named leading IP firm in Spain in the Leaders League rankings 2021
The 2021 Leaders League rankings have just been released and ZBM are once again top of the league for IP…
Read moreZBM continues in the Top Tier of the “IP Stars” rankings 2021 yet another year
After ZBM was awarded Spanish Patent Prosecution Firm of the Year 2021, it’s with great pleasure that we can announce…
Read moreFinancial Times 2021
We are proud to announce that yet again ZBM Patents and Trademarks has been included in the prestigious ratings of…
Read moreProtecting amino acid and nucleic acid sequence variants
The great success of biologics —drugs produced from living organisms or that contain components of living organisms— over the last…
Read more